Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v15-FR Version v14-EN
Language French English
Date Updated 2020-01-16 2020-01-16
Drug Identification Number 00343617 00343617
Brand name ROFACT ROFACT
Common or Proper name ROFACT ROFACT
Company Name BAUSCH HEALTH, CANADA INC. BAUSCH HEALTH, CANADA INC.
Ingredients RIFAMPIN RIFAMPIN
Strength(s) 300MG 300MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL
Packaging size n/a n/a
ATC code J04AB J04AB
ATC description DRUGS FOR TREATMENT OF TUBERCULOSIS DRUGS FOR TREATMENT OF TUBERCULOSIS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2020-02-15 2020-02-15
Actual start date
Estimated end date 2020-03-31 2020-03-31
Actual end date
Shortage status Anticipated shortage Anticipated shortage
Tier 3 Status No No
Company comments currently on manual allocation; new API submission, awaiting response from HC currently on manual allocation; new API submission, awaiting response from HC
Health Canada comments